Our results indicate that the TGFβ-Smad2/3 signaling pathway-induced EMT process is involved in GCB resistance in bladder cancer by transactivating Slug and ZEB2 and downregulating hCNT1 and hENT1. This evidence concerns the gene SNAI2 and urinary bladder carcinoma.